Neoadjuvant pertuzumab-containing regimens improve pathologic complete response rates in stage II-III HER-2/ neu positive breast cancer: a retrospective, single institution experience

Title
Neoadjuvant pertuzumab-containing regimens improve pathologic complete response rates in stage II-III HER-2/ neu positive breast cancer: a retrospective, single institution experience
Authors
Keywords
-
Journal
Clinical Breast Cancer
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2018-07-11
DOI
10.1016/j.clbc.2018.07.008

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started